dennismccain Posted - 1 week ago

$INFU About two and a half weeks ago I said this $6 was headed toward $9 (see below). That’s when I started my position. We’re now there at $9 and we got there pretty fast. Analysts continue to have a target of $14. When I look at the chart I see resistance near $11.50. And then when we get through that level it should move rather quickly up to $15. So I’ll just continue to hold my shares and perhaps add a few shares along the way. Good luck if you’re in on this with me.

StockBraker Posted - 1 week ago

$INFU $14 consensus.

StockBraker Posted - 1 week ago

$INFU Time to break through that 52 week high.

StudBull Posted - 1 week ago

$INFU --B. Riley Adjusts Price Target on InfuSystem to $14 From $13, Maintains Buy Rating $SMTI $XLV $PSCH

Anada1 Posted - 2 weeks ago

$INFU Good beat. LFG!

Anada1 Posted - 2 weeks ago

$INFU Hopefully this ER signals an inflection point. Would probably sell at my entry price of $6.15 if not

StudBull Posted - 2 weeks ago

$INFU Insider stock purchase. Options exercise plus additional purchase through employee stock purchase plan. $SMTI $XLV $PSCH

dennismccain Posted - 10/28/24

$INFU is on my list of candidates for long term holdings. The growth at a reasonable price list. One of the things that has held me back from starting a position has been the size of the company — it’s very small. However, based on my analysis I have a price target of $9 on these shares. That’s 40% higher than the price is being quoted today. And what gives me even more confidence is that the average analyst has a price target even higher than mine — at $13.88. There’s no dividend and the options are monthly, so this company isn’t the ideal candidate for my type of trading, but with a price of $6.42 this should be an entertaining trade. I expect to start a long term position in these shares soon. Multi-year support sits near $6 so somewhere near there is where I’ll place buy orders.

StockBraker Posted - 4 weeks ago

$INFU I am cautiously optimistic here. Very mixed coverage from the Analysts. Wish there were more, better-rated ones covering. Unclear we'll ever get back above $10 anytime soon. Appreciate that the company is continually innovating and seeking out new markets and strategic partnerships. The "proof is in the pudding" based on their upcoming ER results 11/5. Past results have been 50/50 beats and misses.

OneGuyinTN Posted - 1 month ago

Don't miss out on these medical device stocks poised to surge! 🚀 Two companies are leading the way with innovative products, strong financials, and a commitment to improving patient care. Read more to discover the growth potential of these "Strong Buy" picks -> https://tinyurl.com/432atawj #medicaldevices #healthcare #investing #stocks #growth #innovation #tech #TCMD #INFU $TCMD $INFU

StudBull Posted - 1 month ago

$INFU $SMTI $XLV

StockBraker Posted - 1 month ago

$INFU Another price projection

StudBull Posted - 1 month ago

$INFU Video Replay: InfuSystem Holdings, Inc. Fireside Chat Tues 10/1 @ Lytham Partners Fall 2024 Investor Conference https://youtu.be/yYVdxUso6qU?si=hznm6PYJFPdBsWPy

StockBraker Posted - 1 month ago

$INFU We may have hit the bottom in August. Would feel better about the PT's if there were more than 3 covering this company with a bit better ratings.

TipRanks Posted - 1 month ago

These 2 ‘Strong Buy’ Medical Device Stocks Are Poised for Growth, Says Analyst https://www.tipranks.com/news/article/these-2-strong-buy-medical-device-stocks-are-poised-for-growth-says-analyst $INFU $TCMD

Stocksrunner Posted - 09/27/24

Friday Market Action: Analyst Upgrades and Downgrades to Watch: $DELL Gets an AI Boost, Plus Big Analyst Upgrades for $FSLR, $INFU, $SBUX, and $TW—Here’s What You Need to Know! https://stocksrunner.com/Upgrades

StudBull Posted - 09/27/24

$INFU "We believe the stock is significantly undervalued due to non-fundamental hiccups (e.g., earnings misses and delayed filing) and should re-rate as the company continues the momentum seen last quarter—INFU is trading at 1.3x sales and 7.1x adjusted EBITDA vs. the peer group at 2.2x and 11.6x, respectively. We expect sales this year to grow in the high-single digits, with an adjusted EBITDA margin in the high teens on a percentage basis. We further expect margins to exceed 20% within the next 12–24 months." B. Riley analyst Kyle Bauser, Ph.D.

NeoTrinityTrading Posted - 09/26/24

$INFU Upgrade, new contract, insiders buying. I like it!!!!. Not sure if I missed the party. Let's see how the stock perform tomorrow after macroeconomics reports.

StudBull Posted - 09/26/24

$INFU B. Riley initiates $INFU coverage as Buy with a $13 price target

insiderbuyingselling Posted - 09/25/24

$INFU new insider buying: 4000 shares. http://insiderbuyingselling.com/?t=INFU

StudBull Posted - 09/25/24

$INFU Discusses $INFU starting at 5:17 of video https://www.youtube.com/watch?v=4gVJztNyeqQ

6k_investor Posted - 09/23/24

$INFU $DRCR $SGN *URGENT* PARABOLIC PENNY STOCKS TO WATCH WITH HUGE CATALYSTS COMING https://youtu.be/4gVJztNyeqQ

DH_Explorer Posted - 2 months ago

$INFU the new contract is a 50-50 split so even if as a joint venture they capture 10% of the $600M annual market, that's $30M of revenue... $7.5M added to their $31M+ per quarter... think its enough to move the stock towards its $14 price target??? Earnings come up early Nov...

StudBull Posted - 2 months ago

$INFU Volume of almost 30k shares after hours with stock trading as high as $7.28. Someone was/is motivated to buy stock.

StudBull Posted - 2 months ago

$INFU re: new distribution agreement with Chemo Mouthpiece---"In the U.S., there are an estimated 500,000 - 1,000,000 patients who have oral mucositis annually and the estimated market size exceeds $600 million"

Stock_Titan Posted - 2 months ago

$INFU InfuSystem and Sanara MedTech Inc. Announce Exclusive United States Distribution Agreement with ChemoMouthpiece, LLC https://www.stocktitan.net/news/INFU/infu-system-and-sanara-med-tech-inc-announce-exclusive-united-states-wuv1b9rz2r3u.html

DH_Explorer Posted - 2 months ago

$INFU Nice move on this today but seems it gets pulled up and pushed down with the market swings. Can it stand on its own? I will start a small position here and add on the next dip. I think the repurchase over the summer and the owner buying tells a story for the next earnings.

StudBull Posted - 2 months ago

$INFU certainly appears to qualify as stable growth. Thinking they should also benefit from more slack in the labor market. Small cap healthcare sector in general should benefit from lower rates, especially post election

StudBull Posted - 08/27/24

$INFU new S.A. report “Infusystem stock set for strong second half” https://seekingalpha.com/article/4717064-infusystem-stock-set-for-strong-second-half